| Mrs Dina L Galitz, NP | |
|
8600 Old Georgetown Rd, Bethesda, MD 20814-1422 | |
| (301) 896-2654 | |
| Not Available |
| Full Name | Mrs Dina L Galitz |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8600 Old Georgetown Rd, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003950148 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R173381 (Maryland) | Primary |
| 363LF0000X | Nurse Practitioner - Family | 2805892 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dina L Galitz, NP 10314 Strathmore Hall St, Apt 401, North Bethesda, MD 20852-6612 Ph: (301) 897-0321 | Mrs Dina L Galitz, NP 8600 Old Georgetown Rd, Bethesda, MD 20814-1422 Ph: (301) 896-2654 |
News Archive
Research into intermittent preventive treatment of malaria in infants (IPTi) found that one-third of malaria cases in African babies can be prevented by giving them regular doses of malaria drugs even if they have not contracted the disease, according to a Lancet study, published on Thursday, Reuters reports. The study found that IPTi "helped children build better immunity to the disease and reduced the risk of the parasite becoming drug-resistant," but "these benefits decrease if treatment is given continuously as a prophylaxis," Reuters writes.
Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy. The research group headed by Gerhard Hamilton, University Department of Surgery at MedUni Vienna, has now managed to identify the reason for this chemoresistance.
A Continuing Medical Education workshop, "Beating Cardiovascular Disease: Understanding the meaning and value of key risk factors, will be hosted in Phoenix, Arizona on May 14, 2011 by Dr. Sam Fillingane.
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology's annual meeting.
› Verified 2 days ago
Mr. Michael S Stagliano, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr Bldg 10, Bethesda, MD 20892 Phone: 240-507-0883 Fax: 301-480-5598 | |
Mr. Hector Erazo, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-6400 | |
Eliza Staley, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4520 E West Hwy Ste 775, Bethesda, MD 20814 Phone: 667-668-2566 | |
Dr. Margaret Farmar Keil, CRNP, PHD Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: National Institutes Of Health, Nichd, 10 Center Drive, Bldg 10 Room 1 E 3330, Bethesda, MD 20892 Phone: 301-435-3391 Fax: 301-402-1073 | |
Dally Alex, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4954 North Palmer Rd, America Building 19, Third Floor, Bethesda, MD 20889 Phone: 301-319-2900 Fax: 301-319-2901 | |
Olivia Marie Remsberg, CRNP-FAMILY Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9000 Rockville Pike, Bethesda, MD 20892 Phone: 301-496-4000 |